BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Cordis Corporation Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery

  September 5, 2007

   · 

  7 min read
• Drug Development

  Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics

  September 5, 2007

   · 

  1 min read
• Genetown

  Thrombosis Summit 2007 in Boston, Massaschusetts

  September 5, 2007

   · 

  2 min read
• Bio NC

  Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes

  September 5, 2007

   · 

  2 min read
• Drug Development

  Akela Pharma Inc. Announces Positive Results for the Extension Part of its Phase IIb Fentanyl TAIFUN(R) Trial

  September 5, 2007

   · 

  3 min read
• Drug Development

  Biomira Inc. Stimuvax(R) Phase II Data Highlight Three-Year Survival Results for Patients with Non-Small Cell Lung Cancer

  September 5, 2007

   · 

  5 min read
• Business

  PRA International, Inc. Adds Dr. Susan Stansfield as Executive Vice President

  September 5, 2007

   · 

  4 min read
• Drug Development

  Pharmacyclics, Inc. Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients

  September 5, 2007

   · 

  7 min read
• Drug Development

  Lpath, Inc. Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process

  September 5, 2007

   · 

  4 min read
• Business

  Medarex, Inc. Announces Extension of Broad Antibody Development Relationship with Centocor, Inc.

  September 5, 2007

   · 

  3 min read